5/16
08:07 am
vxrt
Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting [Yahoo! Finance]
Low
Report
Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting [Yahoo! Finance]
5/16
08:00 am
vxrt
Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting
Low
Report
Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting
5/15
08:21 am
vxrt
Vaxart Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial [Yahoo! Finance]
Low
Report
Vaxart Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial [Yahoo! Finance]
5/15
08:00 am
vxrt
Vaxart Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial
Low
Report
Vaxart Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial
5/14
04:05 pm
vxrt
Vaxart Publishes Positive, Complete Data from a Phase 2b Challenge Study of its First-Generation Oral Pill Norovirus Vaccine Candidate in Science Translational Medicine
Low
Report
Vaxart Publishes Positive, Complete Data from a Phase 2b Challenge Study of its First-Generation Oral Pill Norovirus Vaccine Candidate in Science Translational Medicine
5/13
04:53 pm
vxrt
Vaxart Provides Business Update and Reports First Quarter 2025 Financial Results [Yahoo! Finance]
Low
Report
Vaxart Provides Business Update and Reports First Quarter 2025 Financial Results [Yahoo! Finance]
5/13
04:14 pm
vxrt
Vaxart appoints Jeroen Grasman as chief financial officer [Seeking Alpha]
Medium
Report
Vaxart appoints Jeroen Grasman as chief financial officer [Seeking Alpha]
5/13
04:05 pm
vxrt
Vaxart Provides Business Update and Reports First Quarter 2025 Financial Results
Medium
Report
Vaxart Provides Business Update and Reports First Quarter 2025 Financial Results
5/13
04:01 pm
vxrt
Vaxart Appoints Jeroen Grasman as Chief Financial Officer
Medium
Report
Vaxart Appoints Jeroen Grasman as Chief Financial Officer
5/12
08:00 am
vxrt
Vaxart Addresses Frequently Asked Questions on Reverse Stock Split Proposal in Definitive Proxy Statement
Medium
Report
Vaxart Addresses Frequently Asked Questions on Reverse Stock Split Proposal in Definitive Proxy Statement
5/5
08:00 am
vxrt
Vaxart CEO Issues Letter to Stockholders Highlighting Company Progress
Medium
Report
Vaxart CEO Issues Letter to Stockholders Highlighting Company Progress
5/2
08:00 am
vxrt
Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13
Medium
Report
Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13
4/30
04:05 pm
vxrt
Vaxart to Present at the Citizens Life Sciences Conference
Medium
Report
Vaxart to Present at the Citizens Life Sciences Conference
4/30
08:34 am
vxrt
Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate [Yahoo! Finance]
Medium
Report
Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate [Yahoo! Finance]
4/30
08:00 am
vxrt
Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate
Medium
Report
Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate
4/16
08:39 am
vxrt
Vaxartto Present at World Vaccine Congress Washington 2025 on April 23 [Yahoo! Finance]
Medium
Report
Vaxartto Present at World Vaccine Congress Washington 2025 on April 23 [Yahoo! Finance]
4/16
08:00 am
vxrt
Vaxartto Present at World Vaccine Congress Washington 2025 on April 23
Medium
Report
Vaxartto Present at World Vaccine Congress Washington 2025 on April 23
3/31
07:59 pm
vxrt
RFK Jr.'s layoffs expected to gut worker safety agency NIOSH, officials say [CBS News]
Medium
Report
RFK Jr.'s layoffs expected to gut worker safety agency NIOSH, officials say [CBS News]
3/27
01:22 pm
vxrt
Vaxart, Inc. (NASDAQ: VXRT) had its price target lowered by analysts at B. Riley from $2.50 to $2.00. They now have a "buy" rating on the stock.
Low
Report
Vaxart, Inc. (NASDAQ: VXRT) had its price target lowered by analysts at B. Riley from $2.50 to $2.00. They now have a "buy" rating on the stock.
3/27
08:00 am
vxrt
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/20
04:01 pm
vxrt
Vaxart Provides Business Update and Reports Full Year 2024 Financial Results
High
Report
Vaxart Provides Business Update and Reports Full Year 2024 Financial Results
3/13
08:00 am
vxrt
Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20
Medium
Report
Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20
3/11
08:00 am
vxrt
Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate
Low
Report
Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate
3/5
07:06 pm
vxrt
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults [Yahoo! Finance]
Medium
Report
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults [Yahoo! Finance]
3/5
04:05 pm
vxrt
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults
Low
Report
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults